Status:
COMPLETED
R-21 Colorectal Cancer Screening (CRCS) Pilot Trial
Lead Sponsor:
M.D. Anderson Cancer Center
Collaborating Sponsors:
National Cancer Institute (NCI)
Conditions:
Colorectal Neoplasms
Eligibility:
All Genders
49-75 years
Phase:
NA
Brief Summary
The goal of this study is to test patient education program for decision making about colorectal cancer (CRC) screening in community health centers.
Detailed Description
Baseline Visit: If you agree to take part in this study, you will complete a questionnaire that asks demographic questions (such as your age and sex) and questions about colorectal cancer. It should ...
Eligibility Criteria
Inclusion
- Male or female patients
- 49 -75 years of age
- English-speaking African American or Spanish-speaking Hispanic patients (upon approval of spanish language arm)
Exclusion
- History of colorectal cancer
- History of polyps
- Any inflammatory bowel disease (IBD), e.g. Crohn's disease or ulcerative colitis
- Family history of colorectal cancer in a first degree relative
- Had fecal occult blood test (FOBT) in the past year, flexible sigmoidoscopy in the past 5 years or colonoscopy in the past 10 years
Key Trial Info
Start Date :
August 7 2012
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 12 2018
Estimated Enrollment :
107 Patients enrolled
Trial Details
Trial ID
NCT01492049
Start Date
August 7 2012
End Date
September 12 2018
Last Update
November 19 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Harris County Hospital District
Houston, Texas, United States, 77030